Five-year outcome of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for Stage III gastric cancer after curative D2 gastrectomy (OGSG0604)

Tamura,Y. Kimura, K. Fujitani, T. Tsuji, J. Matsuyama, S. Iijima, H. Imamura, K. Inoue, K. Kobayashi, Y. Kurokawa, T. Shimokawa, T. Tsujinaka, H. Furukawa ESMO-GI 2014, Barcelona, Spain, 25-28 Jun 2014